Two New Flavonol Glycosides and a Metabolite Profile of Bryophyllum pinnatum, a Phytotherapeutic Used in Obstetrics and Gynaecology

Karin Fürer, Melanie Raith, Rudolf Brenneisen, Mónica Mennet, Ana Paula Simões‐Wüst, Ursula von Mandach, Matthias Hamburger, Olivier Potterat

Planta Medica · 2013 · 54 citations · 20 references

DOIFull text

Open access

Concepts

Abstract

<i>Bryophyllum pinnatum</i> is a succulent perennial plant native to Madagascar which is used in anthroposophical medicine to treat psychiatric disorders and as a tocolytic agent to prevent premature labour. We performed a metabolite profiling study in order to obtain a comprehensive picture of the constituents in <i>B. pinnatum</i> leaves and to identify chromatographic markers for quality control and safety assessment of medicinal preparations. Preliminary HPLC-PDA-ESIMS analyses revealed that flavonoid glycosides were the main UV-absorbing constituents in the MeOH extract of <i>B. pinnatum</i>. Two phenolic glucosides, syringic acid <i>β</i>-<sc>D</sc>-glucopyranosyl ester (<b>1</b>) and 4′-O-<i>β</i>-D-glucopyranosyl-<i>cis</i>-p-coumaric acid (<b>2</b>), as well as nine flavonoids (<b>3</b>-<b>11</b>) including kaempferol, quercetin, myricetin, acacetin, and diosmetin glycosides were unambiguously identified by <sup>1</sup>H and 2D NMR analysis after isolation from a MeOH extract. The flavonol glycosides quercetin 3-O<i>-α</i>-L-arabinopyranosyl-(1 → 2)-<i>α</i>-L-rhamnopyranoside 7-O<i>-β</i>-D-glucopyranoside (<b>3</b>) and myricetin 3-O<i>-α</i>-L-arabinopyranosyl-(1 → 2)-<i>α</i>-L-rhamnopyranoside (<b>4</b>) were new natural products. With the aid of HPLC-PDA-APCIMS and authentic references isolated from the related species <i>B. daigremontianum</i>, the presence of four bufadienolides, bersaldegenin-1-acetate (<b>12</b>), bryophyllin A (<b>13</b>), bersaldegenin-3-acetate (<b>14</b>), and bersaldegenin-1,3,5-orthoacetate (<b>15</b>) was detected in <i>B. pinnatum</i>.

References

20